<DOC>
	<DOCNO>NCT01607021</DOCNO>
	<brief_summary>The aim study investigate relationship interleukin 28B genetic variant response treatment chronic hepatitis C Chinese child .</brief_summary>
	<brief_title>Pharmacogenomics Study IL28B Genetic Variants Chinese Children With Hepatitis C Virus Infection</brief_title>
	<detailed_description>Hepatitis C affect thousand child throughout world . Most child acquire virus vertical transmission , although parenteral route acquisition also common . Affected child usually asymptomatic histological finding mild low risk progression , 5 % develop significant liver disease childhood . The use combination treatment interferon-alpha ribavirin recommend treatment chronic hepatitis C child , SVR child genotype 1 range 44 % 59 % . SVR child genotype 2 3 90 % . But interferon ribavirin significant side effect affect compliance , : repeat flu like symptom , leukopenia anemia , moderate weight loss , behavioural problem , thyroid dysfunction transient deceleration growth rate . In addition , approximately 50 % child infect genotype 1 respond therapy . Recent work highlight single nucleotide polymorphism ( SNPs ) around IL28B gene identify strong predictor spontaneous treatment-induced HCV clearance adult , especially Rs 12979860 Rs 8099917 . A recent article Hepatology also report interleukin ( IL ) -28B C/C genotype child associate spontaneous clearance hepatitis C virus ( HCV ) genotype 1 infection . All report show Genetic Variation Interleukin-28B Locus associate procession CHC . The aim study study association genetic variation IL-28B development CHC Chinese child , : HCV viral load , serum alanine aminotransferase , histological change response treatment interferon-alpha ribavirin .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Aged 118 year Patients chronic HCV infection HCV infect patient previously treat antiviral drug Coinfected Patients HIV Hepatitis B virus ( HBsAg positive ) hepatocellular carcinoma malignancy anticipate difficulty followup observation</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>interleukin 28</keyword>
	<keyword>Children</keyword>
</DOC>